-
Themes
July 1, 2022
Statement from NEHI Regarding Recent SCOTUS Decision to Overturn Roe v. Wade.
-
Themes
Equitable Access to Innovation
June 9, 2022
NEHI and Eli Lilly & Company form a Community Focused Research Organization (CFRO) to promote diversity in clinical trial participation.
-
Themes
Innovations in Healthcare Value and Payment Arrangements
May 4, 2022
Two NEHI member organizations have launched a multi-cancer early detection (MCED) test pilot project. NEHI applies our research on MCED benefit-risk assessment to this initiative.
-
Themes
Innovations in Healthcare Value and Payment Arrangements
February 9, 2022
This NEHI white paper outlines recommendations for benefit-risk assessment of multi-cancer early detection tests (MCEDs).
-
Themes
Innovations in Healthcare Value and Payment Arrangements
February 9, 2022
In this white paper, NEHI recommends that the U.S. Food and Drug Administration collaborate with cancer stakeholder groups and adapt current methods for medical device evaluation to address the capabilities of multi-cancer early detection (MCED) tests for cancer screening.
-
Themes
January 13, 2022
As we enter a new year and the pandemic continues to challenge us individually and collectively, the need for innovations cannot be overstated. At NEHI, we continue to work to advance innovations that address unmet needs and improve health with an increased focus on three priority areas.
-
Themes
Innovations in Healthcare Value and Payment Arrangements
December 20, 2021
This NEHI white paper outlines principles of good communication between health care payers and patients regarding newly approved novel therapies in our health care system.
-
Themes
Innovations in Healthcare Value and Payment Arrangements
December 20, 2021
NEHI has released a report that proposes five principles of communication for shaping exchanges of information among patient groups and U.S. health care payers to enhance and promote trust in payer decision-making on coverage of novel therapies.
-
Themes
Equitable Access to Innovation
December 13, 2021
NEHI has partnered with Eli Lilly & Company and Avalere Health to release a new report today on advancing health and health care equity in the United States.
-
Themes
Equitable Access to Innovation
December 13, 2021
The Roadmap is a guide to improving health equity by deploying digital health solutions and better use of data and analytics that target disparities and measure progress, delivered through expanded access to supportive models of health insurance coverage and care delivery. The Roadmap is based on recommendations from the September 2021 virtual health equity summit organized by Eli Lilly & Company and NEHI, in collaboration with Avalere Health.